The Role of Glutamic or Aspartic Acid in Position Four of the Epitope Binding Motif and Thyrotropin Receptor-Extracellular Domain Epitope Selection in Graves’ Disease
Open Access
- 1 June 2010
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (6) , 2909-2916
Abstract
Context: Development of Graves’ disease (GD) is related to HLA-DRB1*0301 (DR3),and more specifically to arginine at position 74 of the DRB1 molecule. The extracellular domain (ECD) of human TSH receptor (hTSH-R) contains the target antigen. Objective and Design: We analyzed the relation between hTSH-R-ECD peptides and DR molecules to determine whether aspartic acid (D) or glutamic acid (E) at position four in the binding motif influenced selection of functional epitopes. Results: Peptide epitopes from TSH-R-ECD with D or E in position four (D/E+) had higher affinity for binding to DR3 than peptides without D/E (D/E−) (IC50 29.3 vs. 61.4, P = 0.0024). HLA-DR7, negatively correlated with GD, and DRB1*0302 (HLA-DR18), not associated with GD, had different profiles of epitope binding. Toxic GD patients who are DR3+ had higher responses to D/E+ peptides than D/E− peptides (stimulation index 1.42 vs. 1.22, P = 0.028). All DR3+ GD patients (toxic + euthyroid) had higher responses, with borderline significance (Sl; 1.32 vs. 1.18, P = 0.051). Splenocytes of DR3 transgenic mice immunized to TSH-R-ECD responded to D/E+ peptides more than D/E− peptides (stimulation index 1.95 vs. 1.69, P = 0.036). Seven of nine hTSH-R-ECD peptide epitopes reported to be reactive with GD patients’ peripheral blood mononuclear cells contain binding motifs with D/E at position four. Conclusions: TSH-R-ECD epitopes with D/E in position four of the binding motif bind more strongly to DRB1*0301 than epitopes that are D/E− and are more stimulatory to GD patients’ peripheral blood mononuclear cells and to splenocytes from mice immunized to hTSH-R. These epitopes appear important in immunogenicity to TSH-R due to their favored binding to HLA-DR3, thus increasing presentation to T cells.Keywords
This publication has 19 references indexed in Scilit:
- Immune Response of Mice Transgenic for Human Histocompatibility Leukocyte Antigen-DR to Human Thyrotropin Receptor-Extracellular DomainThyroid®, 2009
- Immuno‐informatics: Mining genomes for vaccine componentsImmunology & Cell Biology, 2002
- A Roadmap for HLA-DR Peptide Binding SpecificitiesHuman Immunology, 1997
- HLA Class II Associations in African-American Female Patients with Graves' DiseaseThyroid®, 1996
- The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3Nature, 1995
- T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.The Journal of Clinical Endocrinology & Metabolism, 1995
- Microvariation creates significant functional differences in the DR3 MoleculesHuman Immunology, 1995
- DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 allelesThe Journal of Immunology, 1992
- On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifsThe Journal of Immunology, 1991
- Two major genes, linked to HLA and Gm, control susceptibility to Graves' diseaseNature, 1981